Piper Sandler on BioMarin Pharmaceutical Inc. (BMRN): 'We Remain Bullish After Hosting Management Meetings'
Tweet Send to a Friend
Piper Sandler analyst Allison M. Bratzel reiterated an Overweight rating and $88.00 price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
